Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Meningioma × CNS × Clear all

Status

Sponsor Class

Study Type

Interventional 175 Observational 50 Expanded_access 1

Sponsor

Cancer Type

Conditions

Glioblastoma 15 Neuroblastoma 13 Glioma 11 Pheochromocytoma 7 Neoplasms 6 Recurrence 5 Paraganglioma 5 Pancreatic Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Brain Neoplasms 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neurofibroma, Plexiform 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Astrocytoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Typical Teratoid Rhabdoid Tumor 1 Thyroid cancer, medullary 1 Thyroid Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07497984 2026-03-27

ITM11 Expanded Access Program

ITM Solucin GmbH

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡